Literature DB >> 4063522

Hereditary methemoglobinemia due to cytochrome b5 reductase deficiency in blood cells without associated neurologic and mental disorders.

K Tanishima, K Tanimoto, A Tomoda, K Mawatari, S Matsukawa, Y Yoneyama, H Ohkuwa, E Takazakura.   

Abstract

Following the observation of two fraternal patients without neurologic symptoms, but with hereditary methemoglobinemia due to cytochrome b5 reductase deficiency in erythrocytic and nonerythrocytic cells, a familial study of their paternal and maternal relatives was undertaken. Ferrihemoglobin reductase activities in erythrocytes from the two patients were found to be impaired, and cytochrome b5 reductase activities in platelets and leukocytes were essentially absent. Any deficiencies of the enzyme activities seemed not to be found in nonhematopoietic cells. The enzyme activities in blood cells derived from the parents and some of their paternal and maternal family members showed levels intermediate between those of the patients and those of the normal control, which seemed to be heterozygous. The present cases did not belong to either the classic erythrocytic or the generalized type, and their enzyme deficiency was found rather to be restricted to their blood cells and not associated with neurologic and mental disorders. A necessity of diagnosis by tissues other than blood cells is discussed for a severe form of generalized-type hereditary methemoglobinemia with associated neurologic and mental disorders.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4063522

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  5 in total

1.  Concentration of NADH-cytochrome b5 reductase in erythrocytes of normal and methemoglobinemic individuals measured with a quantitative radioimmunoblotting assay.

Authors:  N Borgese; G Pietrini; S Gaetani
Journal:  J Clin Invest       Date:  1987-11       Impact factor: 14.808

2.  Exonic point mutations in NADH-cytochrome B5 reductase genes of homozygotes for hereditary methemoglobinemia, types I and III: putative mechanisms of tissue-dependent enzyme deficiency.

Authors:  T Katsube; N Sakamoto; Y Kobayashi; R Seki; M Hirano; K Tanishima; A Tomoda; E Takazakura; T Yubisui; M Takeshita
Journal:  Am J Hum Genet       Date:  1991-04       Impact factor: 11.025

3.  NADH-diaphorase deficiency identified in a patient with congenital methaemoglobinaemia detected by pulse oximetry.

Authors:  K Sugahara; T Sadohara; T Kawaguchi; T Hirano
Journal:  Intensive Care Med       Date:  1998-07       Impact factor: 17.440

Review 4.  Drug-induced methaemoglobinaemia. Treatment issues.

Authors:  M D Coleman; N A Coleman
Journal:  Drug Saf       Date:  1996-06       Impact factor: 5.606

5.  Code Blue: Life-threatening Methemoglobinemia.

Authors:  José D Ponce Ríos; Rothsovann Yong; Paul Calner
Journal:  Clin Pract Cases Emerg Med       Date:  2019-03-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.